Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.
Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.
To learn more, visit www.nuvalent.com.
Browse and apply for open jobs at Nuvalent, Inc..
Associate Director leading end - to - end supply chain planning in the pharmaceutical sector. Overseeing planning activities to support global manufacturing and strategic business objectives.
Lead market research, forecasting, and analytics for Nuvalent's NSCLC portfolio. Inform commercial strategy, launch readiness, and cross - functional planning with data - driven insights.
